In addition to gastric balloons and weight-loss surgery, there are also a range of weight-loss drugs (also known as Anti-Obesity Medications) now available some of them touted as miracle treatments for obesity
Do not get defensive if the initial response is lukewarm
[1] [2] The published phase 2 safety tables did not prominently feature alopecia among the most frequently reported adverse events
This review examines dysregulation of the KP in MDD, emphasizing KP metabolites particularly quinolinic acid and kynurenic acid as biomarkers and mediators of excitotoxicity, neuroinflammation, and oxidative stress, and discusses the therapeutic efficacy of antidepressants that modulate this pathway
The choice among these treatments depends on individual health needs, desired outcomes, budget, and local availability, highlighting the importance of consulting healthcare providers for a comprehensive understanding of costs and options